CYDY Company Profile

CYDY Time & Sales

CYDY Recent News

CYDY Filings

CYDY Financials

CYDY Buy Rating

sean007

07/18/2025 7:27:13 PM

IF I remember correctly, We pay Samsung (1)

sean007

07/18/2025 7:23:43 PM

Kat,...glad you mentioned Production (2)

Katangolo

07/18/2025 6:20:12 PM

Its a shame my other post got (10)

Katangolo

07/18/2025 6:17:07 PM

I guess Mike comment about you (5)

My69z

07/18/2025 5:31:36 PM

Yes sir !! Yesss sir!! Upregulating is (3)

KenChowder

07/18/2025 4:42:32 PM

Uh oh. RTB. If he is involved, it is (5)

My69z

07/18/2025 3:58:31 PM

From our FcRn abstract. Experimental (5)

sean007

07/18/2025 3:56:12 PM

Annual Meeting of the Stockholders is (3)

Katangolo

07/18/2025 3:31:02 PM

No, I knew exactly what I was posting (5)

Mr3Putt

07/18/2025 3:16:45 PM

Yeah we're at Lord of the Flies level (9)

biloxiblues

07/18/2025 3:09:24 PM

You can tell we are at the end when we (19)

Evil Rabbit

07/18/2025 2:40:42 PM

Ive posted metadata, federal (11)

Riztheinvestor

07/18/2025 2:39:13 PM

Ok EVIL Here is my Blog. You are (3)

Riztheinvestor

07/18/2025 2:28:39 PM

Ive posted metadata, federal (9)

Evil Rabbit

07/18/2025 2:25:07 PM

Again, youre not actually saying (15)

Riztheinvestor

07/18/2025 2:16:19 PM

You say professional investigations are (12)

Evil Rabbit

07/18/2025 1:54:22 PM

Youre inadvertently illustrating my (12)

Katangolo

07/18/2025 1:43:08 PM

I mean no disrespect in this Evil, but (9)

Katangolo

07/18/2025 1:37:35 PM

Agree, he is one of the front line (3)

Evil Rabbit

07/18/2025 12:05:31 PM

Also, any posts filled with email (8)

Evil Rabbit

07/18/2025 11:56:20 AM

If youre conducting some kind of (20)

Enjay

07/18/2025 11:35:40 AM

With regard to a possible class action (16)

Riztheinvestor

07/18/2025 9:07:50 AM

Well said The truth is already leaking. (4)

DJknows

07/18/2025 9:00:34 AM

While I agree with you Riz, it NEEDS (3)

Riztheinvestor

07/18/2025 8:52:27 AM

Lets be honest this is the real (19)

stevo180

07/18/2025 8:47:09 AM

I knew I saved this for a reason. Its a (5)

DJknows

07/18/2025 8:40:11 AM

As I see it, unless regulators and (5)

DJknows

07/18/2025 8:32:42 AM

Not my words that it would be messy... (3)

docj

07/18/2025 7:14:58 AM

"I believe our current strategy will (10)

Riztheinvestor

07/18/2025 2:07:14 AM

I have an open case on him as well. I (4)

chazzledazzle

07/17/2025 11:55:52 PM

Mr Feuerstein gets sued on average (2)

DJknows

07/17/2025 9:50:49 PM

I don't know if indeed it is true...

Boatbuilder

07/17/2025 8:18:21 PM

Double secret quiet period. (3)

FKAdamF.

07/17/2025 7:45:25 PM

Please let me know if thats true. I (13)

sean007

07/17/2025 7:22:41 PM

I would agree...the absence of (5)

cardamine

07/17/2025 7:15:06 PM

A company can *definitely* say they're (3)

Emmitt

07/17/2025 6:19:05 PM

Anyone here ever considered we might (2)

DJknows

07/17/2025 6:11:51 PM

Anyone hear about this potential (1)

Plotinus

07/17/2025 6:07:03 PM

I keep reminding myself that there is (8)

misiu143

07/17/2025 4:46:08 PM

I tried , 2 times , no response (2)

docj

07/17/2025 4:45:37 PM

Same here hoops. Tyler isn't a big fan (1)

Mr3Putt

07/17/2025 4:39:47 PM

Yes and no. :( (1)

hoops

07/17/2025 4:25:12 PM

I emailed IR twice to ask about the (9)

thriftycents

07/17/2025 3:54:53 PM

And creatv microtech, which caught my (5)

Jake2212

07/17/2025 3:52:59 PM

thriftycents: Merck and GSK are also (6)

Trimble

07/17/2025 2:23:23 PM

Extremely low trading volume today, (3)

My69z

07/17/2025 11:36:20 AM

Mgt has said only keeping oncology & (4)

Cycl2R

07/17/2025 10:49:47 AM

If this is true, it's disappointing to (1)

My69z

07/17/2025 9:09:28 AM

Woops ---That's 3: ......."In fact, the (4)

My69z

07/17/2025 9:05:52 AM

From Hiv publication Mar 31, 2022: "All (5)

Newer

Older

Recent Articles

• Chevron Prepares to Announce Q3 Financial Results Soon
• Exciting Tesla Cybercab Prototype: Steering Wheel Surfaces
• China Leads the Way in Urban Health amidst Climate Challenges
• Zoomlion's Vision for Sustainable Smart Cities Worldwide
• Crédit Agricole S.A. Completes Share Repurchase Program Successfully
• Fresnillo Makes Strategic Move to Acquire Probe Gold
• Projected Growth of Genomics Data Analysis Market to 2034
• Nanobiotix Secures Up to $71 Million in Innovative Funding
• Exciting Launch of $PRDT Token Promises Revenue Sharing Rewards
• Michael Burry's Caution: Avoiding Market Bubbles in 2025
• Rep. Marjorie Taylor Greene Increases Investment in Tech Stocks
• AB Artea Bankas Receives Updated Capital Requirements from ECB
• Mohamed El-Erian Analyzes AI Market: Cautiously Optimistic
• Bekaert's Share Buyback Program and Liquidity Actions Explained
• Sidetrade Partners with NX to Enhance CFO Agility and Growth
• Top Stock Performers: Insights on Major Market Movers
• Facephi Shows Strong Financial Performance and Future Growth
• Kalmar Reports Strong Q3 2025: Profitability and Success in Services
• Loomis Achieves Remarkable Performance in Recent Quarter
• Analyzing Investor Sentiment: Nasdaq's Recent Performance Trends
• Exxon Mobil's Q3 Earnings Preview: Analyst Predictions and Insights
• DXS International's Annual Report: Key Insights and Financials
• Digitalist Group's Third Quarter Review Highlights 2025 Results
• Strong Q3 Results Highlight Growth and Stability for WEHB
• NB Private Equity Partners Effectively Executes Share Buyback
• ICG Enterprise Trust plc Makes Strategic Share Buyback Move
• Understanding the Voting Rights of Northern Venture Trust PLC
• Nanobiotix Partners with Healthcare Royalty for $71 Million Deal
• Fresnillo Enters Agreement to Purchase Probe Gold for C$780M
• Understanding Voting Rights at Northern 2 VCT PLC
• Notable Growth for INVL Technology in 2025 Financials
• Understanding the Latest Net Asset Value of INVL Technology
• Nxera Pharma's Vision Unveiled at Upcoming London Healthcare Conference
• Bioretec Ltd Adjusts H1 Report: Financial Highlights and Outlook
• Tetragon Financial Group Reveals September 2025 Insights
• Bioretec Ltd Updates Financial Report Details for 2025
• Loomis Reports Robust Performance in Q3 2025 with Growth
• Investments from Optiver and Qube Strengthen McKay Brothers
• Strategic Investments by Optiver and QRT Propel McKay Brothers
• Mycenax Partners with RIN Institute to Transform ADC Technology
• Transforming Enterprises: FastGPT's No-code AI Solutions for 2025
• Corbus Pharmaceuticals Moves Forward with Public Offering
• S&P 500 Achieves Historic Winning Streak and Market Insights
• Key Challenges Highlighted by Michael Saylor for Growth Strategy
• Ecer.com Launches Innovative AI Marketplace Strategy for Trade
• Bioretec Ltd Revises 2025 Half-Year Report with Key Updates
• DigitalXForce Achieves Prestigious Leader Status in IDC Assessment
• Danske Bank Sees Positive Trends and Growth for 2025
• Sampo plc's Latest Share Buyback Program and Results
• Exciting Developments in Kudu Well Appraisal by BW Energy